Largest pharmaceuticals by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total liabilities, at $9.2M, followed by Belite Bio ($10.1M) and Oruka Therapeutics ($16.7M). Figures as of 18 Nov 2026, 12:59 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
61
Lowest
Veradermics$9.2M
Median
$2.1B
Combined market value
$5.16T
Countries
10

Market values as of .

Largest pharmaceuticals by total liabilities
#CompanyTotal liabilities ↑Market capPriceToday1 yearPrice, 30 daysCountry
1VeradermicsMANE · Health Care$9.2M$5.3B$125.64 1.88% down 233% up United States
2Belite BioBLTE · Health Care$10.1M$6.4B$157.72 2.98% down 31% up United States
3Oruka TherapeuticsORKA · Health Care$16.7M$6.5B$96.32 2.94% down 241% up United States
4Edgewise TherapeuticsEWTX · Health Care$30.3M$4.6B$42.04 3.75% down 88% up United States
5Dianthus TherapeuticsDNTH · Health Care$37.5M$4.9B$86.98 2.87% down 113% up United States
6Protagonist TherapeuticsPTGX · Health Care$53.5M$8.1B$124.67 0.13% down 46% up United States
7Praxis Precision MedicinesPRAX · Health Care$59.8M$8.5B$305.06 1.68% down 61% up United States
8Spyre TherapeuticsSYRE · Health Care$62.5M$8.9B$93.81 5.60% down 286% up United States
9ErascaERAS · Health Care$71M$4.9B$13.89 8.07% down 403% up United States
10Summit TherapeuticsSMMT · Health Care$92.3M$8.5B$10.67 9.73% down 36% down United States
11Definium TherapeuticsDFTX · Health Care$107.8M$4B$29.38 2.59% down 169% up United States
12ABIVAXABVX · Health Care$143.3M$7.2B$82.10 1.81% down 27% down France
13Corcept TherapeuticsCORT · Health Care$188.8M$7.7B$70.07 1.23% up 8% down United States
14Kiniksa Pharmaceuticals InternationalKNSA · Health Care$196M$7.5B$95.11 0.93% up 126% up United Kingdom
15Rhythm PharmaceuticalsRYTM · Health Care$210.2M$8.1B$116.61 8.49% up 13% up United States
16Cogent BiosciencesCOGT · Health Care$301.2M$4.8B$27.85 1.49% up 20% down United States
17TG TherapeuticsTGTX · Health Care$415.2M$9.5B$62.71 0.08% down 107% up United States
18Roivant SciencesROIV · Health Care$416.3M$28B$38.71 0.26% up 90% up United Kingdom
19Travere TherapeuticsTVTX · Health Care$490.4M$4.9B$51.10 2.82% up 44% up United States
20Mirum PharmaceuticalsMIRM · Health Care$528.1M$6B$91.95 0.40% up 31% up United States
21Ligand PharmaceuticalsLGND · Health Care$543.4M$5.9B$293.81 2.62% down 43% up United States
22Axsome TherapeuticsAXSM · Health Care$601.5M$7.2B$135.95 0.77% down 7% down United States
23Madrigal PharmaceuticalsMDGL · Health Care$656.9M$9.8B$421.99 0.46% down 24% down United States
24AlkermesALKS · Health Care$667.7M$7.6B$45.45 2.32% down 58% up Ireland
25Legend BiotechLEGN · Health Care$731.6M$3.1B$16.11 0.75% up 42% down United States
26United TherapeuticsUTHR · Health Care$783.8M$24.9B$584.10 0.64% down 23% up United States
27Arrowhead PharmaceuticalsARWR · Health Care$881.9M$6.1B$42.99 2.76% down 10% up United States
28BioMarin PharmaceuticalBMRN · Health Care$1.5B$11.3B$58.51 0.90% up 11% up United States
29InsmedINSM · Health Care$1.5B$26.7B$121.86 0.83% down 40% down United States
30Ascendis PharmaASND · Health Care$1.6B$17.8B$271.19 0.20% down 28% up Denmark
31CytokineticsCYTK · Health Care$2.1B$7.2B$51.65 2.86% down 20% down United States
32Dr. Reddy's LaboratoriesRDY · Health Care$2.1B$12.3B$14.79 0.61% up 5% up India
33BridgeBio PharmaBBIO · Health Care$3B$15B$76.80 0.72% down 17% up United States
34Ionis PharmaceuticalsIONS · Health Care$3B$4.5B$26.96 3.75% down 64% down United States
35PTC TherapeuticsPTCT · Health Care$3.1B$5B$60.36 1.00% down 20% down United States
36Amneal PharmaceuticalsAMRX · Health Care$3.7B$7.4B$21.12 0.52% down 83% up United States
37BeOne MedicinesONC · Health Care$3.8B$47.2B$413.26 0.48% up 17% up Switzerland
38Alnylam PharmaceuticalsALNY · Health Care$4.2B$21B$156.50 2.02% down 66% down United States
39Elanco Animal HealthELAN · Health Care$6.8B$12.9B$25.85 2.12% down 20% up United States
40Vertex PharmaceuticalsVRTX · Health Care$7B$135.4B$534.20 0.67% down 27% up United States
41GenmabGMAB · Health Care$7B$32B$51.96 0.76% up 70% up Denmark
42Jazz PharmaceuticalsJAZZ · Health Care$7.3B$15.5B$240.71 0.39% up 37% up Ireland
43Regeneron PharmaceuticalsREGN · Health Care$9.3B$99.1B$957.76 0.56% up 36% up United States
44Royalty PharmaRPRX · Health Care$9.9B$39.5B$68.68 0.23% up 78% up United States
45ZoetisZTS · Health Care$12.1B$33.9B$83.48 1.08% down 29% down United States
46GrifolsGRFS · Health Care$13.4B$5.9B$8.63 1.15% down 1% up Spain
47ViatrisVTRS · Health Care$22.5B$23.4B$20.45 1.40% down 96% up United States
48Teva Pharmaceutical IndustriesTEVA · Health Care$32.8B$49.7B$42.62 0.12% up 74% up Israel
49Abbott LaboratoriesABT · Health Care$33.9B$181.4B$104.71 2.55% down 17% down United States
50Takeda PharmaceuticalTAK · Health Care$50.6B$69.1B$21.64 0.23% up 54% up Japan
51Novo NordiskNVO · Health Care$51.8B$179.4B$40.70 2.16% down 17% down Denmark
52GSKGSK · Health Care$59.9B$98.7B$49.24 2.32% down 6% up United Kingdom
53SanofiSNY · Health Care$61.1B$114.1B$47.53 1.78% down 4% down France
54NovartisNVS · Health Care$64.4B$300.5B$159.13 0.67% down 25% up Switzerland
55AstraZenecaAZN · Health Care$65.4B$282.7B$182.27 0.95% down 2% up United Kingdom
56Bristol-Myers SquibbBMY · Health Care$71.5B$125.4B$61.35 2.51% down 34% up United States
57Merck & CoMRK · Health Care$84.2B$353.4B$143.37 0.75% down 51% up United States
58Eli LillyLLY · Health Care$85.9B$1.26T$1,415.55 1.13% down 35% up United States
59Johnson & JohnsonJNJ · Health Care$117.7B$670.9B$278.70 1.36% down 38% up United States
60PfizerPFE · Health Care$121.4B$162.3B$28.47 1.35% down 14% up United States
61AbbVieABBV · Health Care$137.2B$517.6B$292.82 0.59% down 26% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity.

Questions and answers

Which pharmaceuticals have the lowest total liabilities?

Veradermics ($9.2M), Belite Bio ($10.1M) and Oruka Therapeutics ($16.7M) have the lowest total liabilities of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 12:59 UTC.

How many pharmaceuticals are in this ranking?

61 are ranked by total liabilities.

What are these pharmaceuticals worth together?

The 61 pharmaceuticals ranked by total liabilities have a combined market value of $5.16T as of 18 Nov 2026, 12:59 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.